Animal study · Supplements / medicine · 3 Sept 2026
Some hair loss in men is linked to weight-loss drug use
Source: Medical Xpress
What the research found
Study (genetic). NYU Langone Health researchers led by Lynn Petukhova report in the Journal of Investigative Dermatology that genetically higher GLP-1 receptor (GLP1R) activity is linked to about 7% added risk of male-pattern androgenetic alopecia, remaining after adjustment for hypertension, insulin resistance, and testosterone-related factors. Databases included eQTLGen (31,684 people) and a male complex-traits set (205,327). The analysis could not yet test women the same way. This is not a reason to start, stop, or replace a prescribed GLP-1 drug. Off-label longevity use is clinician-only. Not medical advice.
Evidence level: Animal study. Results in animals or cells often don't carry over to people.
Not medical advice. Not a substitute for a prescribed medicine. Off-label prescription use is clinician-only. VitaLonga does not diagnose, treat, or cure disease. Never start, stop, or replace a prescription with a supplement on the basis of a headline.
More supplements / medicine news
- In mice, the experimental drug KCL-286 reduced DNA breaks and brain inflammation in an Alzheimer's model
- In aged rats, two weeks of the experimental drug cinaciguat cut circulating amyloid-beta about in half and brought LDL down to youthful levels
- In 104 people with a sudden retinal-artery blockage, papaverine use lined up with better functional vision in a retrospective comparison
- A Cell Metabolism letter questions whether a fasting GLP-1 level shows how many gut L-cells a person has
- In FDA reports, caffeine and stimulant supplement use was tied to cardiac arrest about 11 times more often, and 45 percent of those cardiovascular reports were ages 18 to 34